Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Baker Hughes
BKR
$62.3B
| $3.4M | ﹤0.01% |
324,305
-78,321
| -19% | -$1.47M |
|
|
IMMU
427
CALL
DELISTED
Immunomedics Inc
IMMU
| $3.37M | ﹤0.01% |
+250,000
| New | +$4.21M |
|
|
PGTI
428
DELISTED
PGT, Inc.
PGTI
| $3.31M | ﹤0.01% |
394,611
-318,391
| -45% | -$4.52M |
|
|
DCPH
429
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.97M | ﹤0.01% |
72,074
+514
| +0.7% | +$28.5K |
|
|
HES
430
DELISTED
Hess
HES
| $2.96M | ﹤0.01% |
+88,950
| New | +$4.81M |
|
431
KKR & Co
KKR
$92.8B
| $2.88M | ﹤0.01% |
122,899
+68,821
| +127% | +$1.98M |
|
432
CF Industries
CF
$17.7B
| $2.68M | ﹤0.01% |
98,367
+433
| +0.4% | +$16.1K |
|
433
Oracle
ORCL
$413B
| $2.66M | ﹤0.01% |
55,058
+1,551
| +3% | +$80K |
|
434
IBM
IBM
$220B
| $2.54M | ﹤0.01% |
23,927
+461
| +2% | +$58.3K |
|
|
TPIC
435
DELISTED
TPI Composites
TPIC
| $2.49M | ﹤0.01% |
168,367
+3,495
| +2% | +$68.8K |
|
|
MAG
436
DELISTED
MAG Silver
MAG
| $2.45M | ﹤0.01% |
+317,325
| New | +$3.09M |
|
437
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
| $2.21M | ﹤0.01% |
136,790
+29,227
| +27% | +$678K |
|
438
BJs Wholesale Club
BJ
$12.4B
| $2.1M | ﹤0.01% |
+82,288
| New | +$1.85M |
|
439
Aramark
ARMK
$14.8B
| $2.04M | ﹤0.01% |
+141,148
| New | +$3.72M |
|
440
Altria Group
MO
$113B
| $2.01M | ﹤0.01% |
+51,896
| New | +$2.3M |
|
441
Amgen
AMGN
$219B
| $1.99M | ﹤0.01% |
9,834
-5,467
| -36% | -$1.19M |
|
442
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
| $1.96M | ﹤0.01% |
+95,985
| New | +$3.03M |
|
|
DOC
443
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.9M | ﹤0.01% |
+136,520
| New | +$2.51M |
|
444
Vanguard Morningstar Growth ETF
VUG
$229B
| $1.89M | ﹤0.01% |
72,288
+63,384
| +712% | +$1.9M |
|
445
Kirby Corp
KEX
$7.02B
| $1.87M | ﹤0.01% |
+43,022
| New | +$2.93M |
|
|
PXD
446
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.82M | ﹤0.01% |
25,900
-26,283
| -50% | -$3.12M |
|
447
Service Corp International
SCI
$11.6B
| $1.7M | ﹤0.01% |
43,412
+36,925
| +569% | +$1.72M |
|
448
JD.com
JD
$44.3B
| $1.69M | ﹤0.01% |
+41,594
| New | +$1.66M |
|
449
Copart
CPRT
$26.9B
| $1.68M | ﹤0.01% |
98,040
+33,360
| +52% | +$742K |
|
450
Tyler Technologies
TYL
$12.5B
| $1.65M | ﹤0.01% |
5,564
+1,242
| +29% | +$385K |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.